CN102487980A - 绞股蓝微粉莲蓉 - Google Patents
绞股蓝微粉莲蓉 Download PDFInfo
- Publication number
- CN102487980A CN102487980A CN2011103824226A CN201110382422A CN102487980A CN 102487980 A CN102487980 A CN 102487980A CN 2011103824226 A CN2011103824226 A CN 2011103824226A CN 201110382422 A CN201110382422 A CN 201110382422A CN 102487980 A CN102487980 A CN 102487980A
- Authority
- CN
- China
- Prior art keywords
- gynostemma pentaphylla
- lotus seed
- micro
- seed paste
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 title claims abstract description 29
- 240000006509 Gynostemma pentaphyllum Species 0.000 title claims abstract description 28
- 240000002853 Nelumbo nucifera Species 0.000 title claims abstract description 18
- 235000006508 Nelumbo nucifera Nutrition 0.000 title claims abstract description 18
- 235000006510 Nelumbo pentapetala Nutrition 0.000 title claims abstract description 18
- 239000000843 powder Substances 0.000 title abstract description 9
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 12
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims abstract description 12
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 4
- 239000008158 vegetable oil Substances 0.000 claims abstract description 4
- 239000003595 mist Substances 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 18
- 210000004369 blood Anatomy 0.000 abstract description 18
- 235000000346 sugar Nutrition 0.000 abstract description 7
- 206010020772 Hypertension Diseases 0.000 abstract description 5
- 230000036772 blood pressure Effects 0.000 abstract description 5
- 230000000881 depressing effect Effects 0.000 abstract 2
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 208000001953 Hypotension Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000002218 hypoglycaemic effect Effects 0.000 description 6
- 208000021822 hypotensive Diseases 0.000 description 6
- 230000001077 hypotensive effect Effects 0.000 description 6
- 235000014347 soups Nutrition 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000012467 final product Substances 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical group COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 3
- 229930187479 gypenoside Natural products 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000005253 cladding Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000003345 hyperglycaemic effect Effects 0.000 description 2
- 230000003516 hyperlipidaemic effect Effects 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical class O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001065361 Gynostemma Species 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 241000545744 Hirudinea Species 0.000 description 1
- 235000013717 Houttuynia Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960004580 glibenclamide Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229930186669 gynosaponin Natural products 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000005272 metallurgy Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 108700022737 rat Fat1 Proteins 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
Abstract
绞股蓝微粉莲蓉；本发明提供了一种具有降血压、降血脂、降血糖保健功能的莲蓉，其技术方案是：按重量百分比构成包括莲子30-70％、罗汉果5-15％、植物油10-20％、绞股蓝微粉15-30％；所述绞股蓝微粉是绞股蓝用超微粉碎机制成的微粉。本发明具有降血压、降血脂、降血糖保健功能，适用于高血压、高血脂、高血糖等患者或广大消费者日常食品的辅助保健。
Description
技术领域
本发明涉及一种绞股蓝微粉莲蓉，尤其是一种具有降血压、降血脂、降血糖保健功能的莲蓉。
背景技术
绞股蓝系葫芦科草质藤本植物，主要有效成份是绞股蓝皂甙、绞股蓝糖甙(多糖)、水溶性氨基酸、黄酮类、多种维生素、微量元素、矿物质等。绞股蓝性味寒；苦；归肺、脾、肾经。功能与主治：调节血压，降低血脂，调节血糖，促进尿酸排泄；用于血脂、血压、血糖、血尿酸过高、高或异常者。绞股蓝的药理作用：免疫调节，抗衰老，抗肿瘤，安神养心。
绞股蓝降血压、降血糖的疗效。如论文《绞股蓝治疗糖尿病和高血压病临床观察》(《中西医结合实用临床急救》1998年06期)王俊棠、刘修芹、李刚、徐大勇、朱士文等为寻求糖尿病、高血压安全有效的治疗药物，观察绞股蓝治疗糖尿病和高血压病的疗效。方法：将60例糖尿病患者随机分为绞股蓝组、优降糖组及绞股蓝与优降糖合用组(各20例)；60例高血压病患者分为绞股蓝组、心痛定组及绞股蓝与心痛定合用组(各组20例)，比较3组疗效。结果：治疗2周后绞股蓝能显著地降血糖、降血压，患者治疗前后比较血糖和血压均有非常显著性差异(P＜0.05)，与优降糖组或心痛定组比较，差异无显著性(P＞0.05)；而联合用药组，疗效则更显著(P＜0.01)。结论：绞股蓝是一种有效的降血糖、降血压的药物。
绞股蓝降血脂的疗效。如论文《绞股蓝滴丸对实验性高血脂大鼠的降血脂作用研究》(《中国科学院上海冶金研究所材料物理与化学(专业)博士论文2000年度》)张炜平、马玉亭、许华等用大鼠建立高血脂症动物模型观察绞股蓝滴丸对大鼠血脂各项生化指标的影响。结果表明，2个剂量的绞股蓝滴丸(40mg/kg、120mg/kg绞股蓝总甙)在预防给药和治疗给药试验中均可明显降低造型后大鼠血液中胆固醇(TC)、甘油三酯(TG)和低密度脂蛋白(LDL)的含量，升高高密度脂蛋白HDL/LDL的比值。
超微粉碎技术是将物质粉碎成直径小于10μm(即300目以上)粉体的高科技含量的工业技术，具有速度快、时间短、粒径细、分布均匀、节省原料等特点。目前中药超微粉碎以单味中药的粉碎研究较多，经过对灵芝孢子粉、桑叶、紫河车、三七、甘草、丹参、黄连药材、葛根、枳壳、鱼腥草、人参、天麻、西洋参、水蛭等多种中药材的超微粉碎后的研究结果表明：超微粉碎技术能够增加中药的溶出率和生物利用度、减少中药的用量、保留中药的挥发性活性成分、增强药理作用以及提高比表面积、改善颗粒的均匀性等。
绞股蓝应用超微粉碎技术制成微粉，相对绞股蓝煎汁，主要有以下优势：1、提高绞股蓝皂苷的溶出度；2、提高绞股蓝皂苷的生物利用率；3、增强药效；4、减少剂量，节省原料，提高效率，降低成本。
近年专利文献中涉及营养保健的莲蓉中，没有配用绞股蓝制成的产品；专利申请号为200710019058的发明——一种保健月饼，该保健月饼由皮料和馅料加工而成，其要点是在皮料和馅料中都添加有绞股蓝提取物，但该发明申请局限于月饼馅料。
发明内容
本发明的目的是要提供一种具有降血压、降血脂、降血糖等保健功效的绞股蓝微粉莲蓉，且适用于各种糕点馅料。
本发明是这样实现的：按重量百分比构成包括莲子30-70％、罗汉果5-15％、植物油10-20％、绞股蓝微粉15-30％；所述绞股蓝微粉是绞股蓝用超微粉碎机制成的微粉。
本发明绞股蓝微粉莲蓉的制作步骤如下：
1、制备莲子浆：将莲子磨皮去芯后，放进蒸汽锅中煮成泥浆状；
2、制备罗汉果提取液：将罗汉果放进锅中，摊平，然后加入高出药面3～4厘米的水，浸泡20-30分钟，然后加盖加热煎煮；先用武火加热至100℃，再用文火煎煮10-25分钟后，滤取第一次药液；然后加热水适量，依上法煎煮，取第二次药液。将两次药液混匀即可；
3、将莲子浆和罗汉果提取液、绞股蓝微粉放进锅中拌匀，翻炒；分2-3次放进植物油，将以上莲子浆炒干，冷却后分装即可。
本发明相对传统莲蓉或绞股蓝煎汁制成浸膏配制莲蓉馅料，其优点是：
1、降血压、降血脂、降血糖的效果显著。实验证明：分别给10名高血压患者、10名高血脂患者、10名高血糖患者服用本发明绞股蓝莲蓉制成的莲蓉面包，每人每天所用绞股蓝莲蓉食用量120g，分3次，每次40g，每次间隔4小时；20天后测量：10名高血压患者收缩压分别降低10-25mmHg不等，10名高血脂患者血脂总胆固醇分别降低1.0-4.5mmol/L不等，10名高血糖患者血糖分别降低1.5-4.5mmol/L不等。
2、用罗汉果取代传统莲蓉的砂糖，更适合糖尿病患者。罗汉果，甜度约是蔗糖的300倍，甜味类似菊糖，浓郁芬芳可口，是糖尿病患者的优良天然糖代品。中医用之入药，取其清肺止咳、润肠通便之功。
具体实施方式
一种绞股蓝微粉莲蓉，配料组成包括：莲子70kg、罗汉果5kg、花生油10kg、绞股蓝微粉15kg。
制作步骤如下：
1、制备莲子浆：将莲子磨皮去芯后，放进蒸汽锅中煮成泥浆状；
2、制备罗汉果提取液：将罗汉果放进锅中，摊平，然后加入高出药面3～4厘米的水，浸泡20分钟，然后加盖加热煎煮；先用武火加热至100℃，再用文火煎煮10-25分钟后，滤取第一次药液；然后加热水适量，依上法煎煮，取第二次药液；将两次药液混匀即可；
3、将莲子浆和罗汉果提取液、绞股蓝微粉放进锅中拌匀，翻炒；分3次放进花生油，将以上莲子浆炒干，冷却后分装即可。
Claims (1)
1.一种绞股蓝微粉莲蓉，其特征是：按重量百分比构成包括莲子30-70％、罗汉果5-15％、植物油10-20％、绞股蓝微粉15-30％；所述绞股蓝微粉是绞股蓝用超微粉碎机制成的微粉。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103824226A CN102487980B (zh) | 2011-11-28 | 2011-11-28 | 绞股蓝微粉莲蓉 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103824226A CN102487980B (zh) | 2011-11-28 | 2011-11-28 | 绞股蓝微粉莲蓉 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102487980A true CN102487980A (zh) | 2012-06-13 |
| CN102487980B CN102487980B (zh) | 2013-06-05 |
Family
ID=46179899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103824226A Active CN102487980B (zh) | 2011-11-28 | 2011-11-28 | 绞股蓝微粉莲蓉 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102487980B (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102696733A (zh) * | 2012-06-29 | 2012-10-03 | 南宁明顶商旅有限公司 | 绞股蓝广式莲蓉月饼的制作方法 |
| CN109998072A (zh) * | 2019-04-26 | 2019-07-12 | 刘仲美 | 无添加剂的莲蓉馅料制备方法 |
| CN110037081A (zh) * | 2019-03-21 | 2019-07-23 | 深圳市麦轩食品有限公司 | 一种低糖老婆饼及其制备工艺 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1600179A (zh) * | 2003-09-22 | 2005-03-30 | 桂林思特新技术公司 | 罗汉果果珍 |
| CN101433310A (zh) * | 2007-11-13 | 2009-05-20 | 张钊 | 一种保健月饼 |
-
2011
- 2011-11-28 CN CN2011103824226A patent/CN102487980B/zh active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1600179A (zh) * | 2003-09-22 | 2005-03-30 | 桂林思特新技术公司 | 罗汉果果珍 |
| CN101433310A (zh) * | 2007-11-13 | 2009-05-20 | 张钊 | 一种保健月饼 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102696733A (zh) * | 2012-06-29 | 2012-10-03 | 南宁明顶商旅有限公司 | 绞股蓝广式莲蓉月饼的制作方法 |
| CN110037081A (zh) * | 2019-03-21 | 2019-07-23 | 深圳市麦轩食品有限公司 | 一种低糖老婆饼及其制备工艺 |
| CN109998072A (zh) * | 2019-04-26 | 2019-07-12 | 刘仲美 | 无添加剂的莲蓉馅料制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102487980B (zh) | 2013-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102396615B (zh) | 一种红枣补血八宝茶饮料及其制备方法 | |
| CN102178867B (zh) | 一种益气健脾补肾的中药方剂及其制品 | |
| CN101647872A (zh) | 一种牡丹精油软胶囊及其制备方法 | |
| CN103468391B (zh) | 一种固本养肾葵花籽油的制备方法 | |
| CN105875938A (zh) | 一种野菊花茶及其制作方法 | |
| CN108029821A (zh) | 杜仲固体保健茶及其制备方法 | |
| CN102488009A (zh) | 绞股蓝保健奶粉 | |
| CN103417612B (zh) | 一种中药炮制的葛根饮片及其制备方法 | |
| CN102487980B (zh) | 绞股蓝微粉莲蓉 | |
| CN104126636A (zh) | 一种何首乌菊花薏米饼及其制备方法 | |
| CN102640921A (zh) | 一种食品延缓衰老茶冲剂 | |
| CN102178004A (zh) | 一种保健普洱茶饮品 | |
| CN102178858A (zh) | 益气宁心养生膏的配方及其制备方法 | |
| CN103536860A (zh) | 一种改善睡眠的保健品 | |
| CN103461539A (zh) | 一种茶香保健棉籽油的制备方法 | |
| CN102362668A (zh) | 绞股蓝龟苓膏 | |
| KR20180001313A (ko) | 발모에 유용한 외용제 조성물의 제조방법 | |
| CN101313994A (zh) | 用于治疗心房颤动中药胶囊 | |
| CN108143833A (zh) | 一种甘草饮片的制备方法 | |
| CN104336286B (zh) | 一种具有降压作用的巧玲花保健糖果及其制备方法 | |
| CN102487974A (zh) | 海带微粉莲蓉 | |
| CN102487981A (zh) | 绞股蓝保健莲蓉 | |
| CN101991806A (zh) | 安胎保产液和胶囊 | |
| CN102397470A (zh) | 养颜祛斑膏及其制法 | |
| CN105285223A (zh) | 一种四季滋补茶及其制作方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181217 Address after: 225321 No. 11 Xuzhuang Xingwang Road, Gaogang District, Taizhou City, Jiangsu Province Patentee after: Zhao Lanrong Address before: 542601 Hope Science and Technology Research Center, 23 Pingwan North Road, Pinggui Administrative Zone, Hezhou City, Guangxi Zhuang Autonomous Region (next to the Science and Technology Bureau) Patentee before: Lai Yanning |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20191219 Address after: No. 406, Qishe village, Yongfeng Town, Xinghua City, Taizhou City, Jiangsu Province Patentee after: Qi Minghai Address before: 225321 No. 11 Xuzhuang Xingwang Road, Gaogang District, Taizhou City, Jiangsu Province Patentee before: Zhao Lanrong |
|
| TR01 | Transfer of patent right | ||
| CP02 | Change in the address of a patent holder |
Address after: Room 302, No. 260, Renmin Middle Road, Jiangyan District, Taizhou City, Jiangsu Province Patentee after: Qi Minghai Address before: No. 406, Qishe village, Yongfeng Town, Xinghua City, Taizhou City, Jiangsu Province Patentee before: Qi Minghai |
|
| CP02 | Change in the address of a patent holder | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20230403 Address after: 710000 Room 1902, Building C, Zhengshang International, Xi'an Economic and Technological Development Zone, Shaanxi Province Patentee after: Shaanxi Shenjiang Zhipeng Health Technology Co.,Ltd. Address before: 225500 Room 302, 260 Renmin Middle Road, Jiangyan District, Taizhou City, Jiangsu Province Patentee before: Qi Minghai |
|
| TR01 | Transfer of patent right |